Logo - springer
Slogan - springer

Life Sciences - Cell Biology | Cell Biology and Toxicology - incl. option to publish open access (Editorial Board)

We’re working on a new version of this journal site - preview it now
Cell Biology and Toxicology

Cell Biology and Toxicology

An International Journal Devoted to Research at the Cellular Level

Editor-in-Chief: Xiangdong Wang

ISSN: 0742-2091 (print version)
ISSN: 1573-6822 (electronic version)

Journal no. 10565

80,33 € Personal Rate e-only
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 6 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy


Xiangdong Wang, MD, PhD
Distinguished Professor of Medicine, Director of Shanghai Institute of Clinical Bioinformatics, Director of Fudan University Center for Clinical Bioinformatics,
Director of Biomedical Research Center of Fudan University Zhongshan Hospital,
Shanghai, China

Honorary Editors:
Professor Andre Guillouzo
Dr. Charlene McQueen
Michael Welsh

Founding Editor: Gary Williams

Editorial Board

Angela Hague, School of Oral and Dental Sciences, Faculty of Medicine and Dentistry, Bristol, UK

Timothy C. Marrs, Edentox Associates, Edenbridge, Kent, UK

Xinxin Ding, PhD, Professor, College of Nanoscale Science, SUNY Polytechnic Institute, Albany, NY, USA

Reen Wu, PhD, Professor of Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of California at Davis, School of Veterinary Medicine, Davis, California, USA

Kenneth Adler, PhD, Professor of Cell Biology, Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, USA

Winfried Römer, Prof. Dr.Institute of Biology II and BIOSS Centre for Biological Signalling Studies, Freiburg, Germany

Benjamin Geiger, Professor of Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel

Jörg Grosshans, Professor, Institute for Developmental Biochemistry, Medical School, Georg-August-University Göttingen, Göttingen, Germany

Jean-Yves Bouet, PhD, CNRS Research Director, Laboratoire de Microbiologie et Génétique Moléculaires, Centre National de la Recherche Scientifique and University of Toulouse Paul Sabatier, Toulouse, France

Douglas S. Richardson, PhD, Director of Imaging, Harvard Center for Biological Imaging, Department of Molecular and Cellular Biology, Harvard University, Cambridge, USA

Michael S. Goldberg, Professor, Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, USA

Dirk Heckl, Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany

Peter Bai, PhD, DSc, Associate Professor and Head of MTA-DE Lendület Laboratory of Cellular Metabolism, Research Center for Molecular Medicine, Dept. of Medical Chemistry University of Debrecen, Debrecen, Hungary

Miguel A. Esteban, Professor, Hong Kong-Guangdong Joint Laboratory on Stem Cell and Regenerative Medicine, the University of Hong Kong and Guangzhou Institutes of Biomedicine and Health, China

Robert Smith, PhD, Professor and Vice President, Cancer Screening, American Cancer Society, Atlanta, USA

Jean-Yves Bouet, Professor and Head, Laboratoire de Microbiologie et Génétique Moléculaires, Centre National de la Recherche Scientifique, Toulouse, France

Dan Peer PhD, Professor and Head of Laboratory of NanoMedicine, Department of Cell Research & Immunology, Department of Materials Science & Engineering, Director of FTA:Nanomedicines for Personalized Theranostics, Director of Leona M. and Harry B. Helmsley Nanotechnology Research Fund, Israel

Darren R. Williams, PhD, Associate Professor, New Drug Targets Laboratory, School of Life Science, Gwangju Institute of Science and Technology, Republic of Korea

Christian Baumgartner PhD, Professor of Health Care and Biomedical Engineering, Institute of Health Care Engineering with European Notified Body of Medical Devices, Graz University of Technology; Institute of Electrical and Biomedical Engineering-Research Group for Clinical Bioinformatics, University of Health Sciences, Medical Informatics and Technology, Austria

Tian Xu, PhD, Professor and Vice Chair of Genetics, Yale University School of Medicine, Investigator of Howard Hughes Medical Institute, Director of Institute of Developmental Biology & Molecular Medicine, Fudan University, New Haven, USA

Peter A. Ward, MD, Godfrey D. Stobbe Professor of Pathology, University of Michigan Medical School, Department of Pathology, Ann Arbor, USA

Gary L Firestone, PhD, Professor of Cell and Developmental Biology, Dept. of Molecular and Cell Biology, The University of California at Berkeley, Berkeley, USA

Drago Cretoiu, MD, PhD, Assistant Professor, Department of Cellular and Molecular Medicine, Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy and 'Victor Babes' National Institute of Pathology, Bucharest, Romania


For authors and editors

  • Journal Citation Reports®
    2018 Impact Factor
  • 5.097
  • Aims and Scope

    Aims and Scope


    Cell Biology and Toxicology (CBT) is an international journal focused on clinical and translational research with an emphasis on molecular and cell biology, genetic and epigenetic heterogeneity, drug discovery and development, and molecular pharmacology and toxicology. CBT has a disease-specific scope prioritizing publications on gene and protein-based regulation, intracellular signaling pathway dysfunction, cell type-specific function, and systems in biomedicine in drug discovery and development. CBT publishes original articles with outstanding, innovative and significant findings, important reviews on recent research advances and issues of high current interest, opinion articles of leading edge science, and rapid communication or reports, on molecular mechanisms and therapies in diseases.



    1.       Gene and protein-based regulations in diseases

    CBT welcomes submissions in the fields of genomics and proteomic, functional genomics and proteomics, computational biology, and gene expression and function. CBT particularly includes aspects of the multifactorial genetics and epigenetics of diseases, disease-specific biomarkers, developmental biology, systems biology and bioinformatics-based data mining approaches with translational potentials.


    2.       Molecular pharmacology and toxicology

    CBT specially focuses on drug target identification and validation, rational drug design, genetic/small molecule (high-throughput) screening, novel therapeutic approaches, combinatorial and parallel synthesis of drugs, pharmacokinetics and pharmacodynamics, pharmacogenomics and toxicogenomics.


    3.       Pathological mechanisms related with intracellular organelles and cells

    CBT publishes novel findings on membrane biology and domains, and the associated receptor and non-receptor mediated signaling and transport proteins of the cell membrane, mitochondria, the endoplasmic reticulum, Golgi apparatus, and other organelles in health and disease. On the cellular and organism level, CBT aims to understanding cancer development, maintenance and treatment resistance, immune and inflammatory cell function, neuroscience, stem cell development and differentiation, epithelial biology and endothelial barrier function.


    4.       Biomedical aspects of organ systems in diseases

    CBT primarily publishes studies on the immune system, central and autonomic nervous systems, gastrointestinal system, cardiovascular and circulatory system, endocrine system, and pulmonary system, skeletal and muscular system, and urinary system to understand deeper about pathogeneses and therapies.



  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors
  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer Science+Business Media Dordrecht

Alerts for this journal


Get the table of contents of every new issue published in Cell Biology and Toxicology.

Additional information